Abandon the mouse research ship? Not just yet!

Shock

Volumn 41, Issue 6, 2014, Pages 463-475

  Osuchowski, Marcin F ^a   Remick, Daniel G ^b   Lederer, James A ^c   Lang, Charles H ^d   Aasen, Ansgar O ^e   Aibiki, Mayuki ^f   Azevedo, Luciano C ^g   Bahrami, Soheyl ^a   Boros, Mihaly ^h   Cooney, Robert ⁱ   Cuzzocrea, Salvatore ^j   Jiang, Yong ^k   Junger, Wolfgang G ^l   Hirasawa, Hiroyuki ^m   Hotchkiss, Richard S ⁿ   Li, Xiang An ^o   Radermacher, Peter ^p   Redl, Heinz ^a   Salomao, Reinaldo ^q   Soebandrio, Amin ^r   Thiemermann, Christoph ^s   Vincent, Jean Louis ^t   Ward, Peter ^u   Yao, Yong Ming ^v   Yu, Huang Ping ^w   Zingarelli, Basilia ^x   Chaudry, Irshad H ^y   more..

^a AUVA Soziale Unfallversicherung   (Austria)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f EHIME UNIVERSITY   (Japan)

^g HOSPITAL SÍRIO LIBANÊS   (Brazil)

^h UNIVERSITY OF SZEGED   (Hungary)

ⁱ SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^j UNIVERSITY OF MESSINA   (Italy)

^k SOUTHERN MEDICAL UNIVERSITY   (China)

^l HARVARD MEDICAL SCHOOL   (United States)

^m CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁿ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF KENTUCKY   (United States)

^p UNIVERSITY HOSPITAL ULM   (Germany)

^q FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^r UNIVERSITY OF INDONESIA   (Indonesia)

^s QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^t ERASME HOSPITAL   (Belgium)

^u UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^v CHINESE PLA GENERAL HOSPITAL   (China)

^w CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^x CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^y UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

burn; endotoxemia; Mouse models of critical illness; sepsis; trauma

Indexed keywords

ENDOTOXIN; GELATINASE A; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; BACTEREMIA; BASIC RESEARCH; BLADDER CANCER; BLOOD TRANSFUSION; CHRONIC KIDNEY DISEASE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; END STAGE RENAL DISEASE; ENDOTOXEMIA; GENE EXPRESSION PROFILING; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INJURY SEVERITY; INTENSIVE CARE; INTENSIVE CARE UNIT; LEUKOCYTE; LEWIS CARCINOMA; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SEPSIS; SEPTIC SHOCK; ANIMAL; FEMALE; GENETICS; GENOMICS; MALE;

ANIMALS; FEMALE; GENOMICS; HUMANS; INFLAMMATION; MALE;

EID: 84901626481     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000153     Document Type: Review

References (196)

1. US Congress, Office of Technology Assessment. Alternatives to Animal Use in Research, Testing, and Education. Washington, DC: US Government Printing Office; February 1986. OTA-BA-273. Available at: Http://govinfo. library.unt.edu/ota/Ota-3/DATA/1986/8601. Accessed October 25, 2013
2. Sixth Report on the Statistics on the Number of Animals used for Experimental and other Scientific Purposes in the Member States of the European Union, 2010. Available at: Http://www.europarl.europa.eu/registre/docs-autres- institutions/ commission-europeenne/sec/2010/1107/COM-SEC%282010%291107-EN. Accessed October 25, 2013
3. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, et al.: Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 110(9):3507-3512, 2013
4. Bolker J: Model organisms: Theres more to life than rats and flies. Nature 491(7422):31-33, 2012
5. Handel AE, Lincoln MR, Ramagopalan SV: Of mice and men: Experimental autoimmune encephalitis and multiple sclerosis. Eur J Clin Invest 41(11): 1254-1258, 2011
6. Mestas J, Hughes CC: Of mice and not men: Differences between mouse and human immunology. J Immunol 172(5):2731-2738, 2004
7. Kolata G: Mice Fall Short as Test Subjects for Humans Deadly Ills. February 12, 2013 (nytimes.com): Available at: Http://www.nytimes.com/2013/02/ 12/ science/testing-of-some-deadly-diseases-on-mice-mislead-reportsays. html?pagewanted=1&-r=3&ref=global-home&comments. Accessed October 25, 2013
8. In science.slashdot.org. February 12, 2013. Available at: Http://science. slashdot.org/story/13/02/12/1823238/drug-testing-in-mice-may-be-a-wasteof- time-researchers-warn. Accessed October 25, 2013
9. Love SM:We are notmice. February 14, 2013 (Huffingtonpost.com).Available at: Http://www.huffingtonpost.com/susan-m-love/research-mice-b-2680201.html. Accessed October 25, 2013
10. Derek L: Mouse models of inflammation are basically worthless. Now We Know. February 12, 2013 (pipeline.corante.com). Available at: Http://pipeline. corante.com/archives/2013/02/13/mouse-models-of-inflammation-are- basically-worthless-now-we-know.php. Accessed October 25, 2013
11. Chu E: This is why its a mistake to cure mice instead of humans. December 20, 2012 (richarddawkins.net). Available at: Http://www.popsci.com/science/ article/2013-02/how-scientists-got-lost-curing-mice-instead-of-humans. Accessed October 25, 2013
12. Cauwels A, Vandendriessche B, Brouckaert P: Of mice, men, and inflammation. Proc Natl Acad Sci U S A 110(34):E3150, 2013
13. de Souza N: Model organisms: Mouse models challenged. Nat Methods 10(4): 288, 2013
14. Perlman H, Budinger GR, Ward PA: Humanizing the mouse: In defense of murine models of critical illness. Am J Respir Crit Care Med 187(9): 898-900, 2013
15. Osterburg AR, Hexley P, Supp DM, Robinson CT, Noel G, Ogle C, Boyce ST, Aronow BJ, Babcock GF: Concerns over interspecies transcriptional comparisons in mice and humans after trauma. Proc Natl Acad Sci U S A 110(36):E3370, 2013
16. Drake AC: Of mice and men: What rodent models dont tell us. Cell Mol Immunol 10(4):284-285, 2013
17. Cossin D: Do Mice Make Bad Models? The Scientist. February 11, 2013. Available at: Http://www.the-scientist.com/?articles.view/articleNo/34346/title/ Do-Mice-Make-Bad-Models-/. Accessed October 25, 2013
18. Barrington B: Are mice reliable models for human disease studies? Understand Nutrition, February 14, 2013. Available at: Http:// understandnutrition. com/2013/02/14/are-mice-reliable-models-for-human-disease- studies/. Accessed October 25, 2013
19. Wanner M: Why mice may succeed in research when a single mouse falls short? Genetics and Your Health Blog, February 13, 2013. Available at: Http://community.jax.org/genetics-health/b/weblog/archive/2013/02/13/ why-mice-may-succeed-in-research-when-a-single-mouse-fallsshort. aspx. Accessed October 25, 2013
20. Remick D: Use of animal models for the study of human disease-a shock society debate. Shock 40(4):345-346, 2013
21. Sadarangani C, Skamene E, Kongshavn PA: Cellular basis for genetically determined enhanced resistance of certain mouse strains to listeriosis. Infect Immun 28(2):381-386, 1980
22. Liu B, Koo GC, Yap EH, Chua KL, Gan YH: Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun 70(2):504-511, 2002
23. Brenner GJ, Cohen N, Moynihan JA: Similar immune response to nonlethal infection with herpes simplex virus-1 in sensitive (BALB/c) and resistant (C57BL/6) strains of mice. Cell Immunol 157(2):510-524, 1994
24. Guida JD, Fejer G, Pirofski LA, Brosnan CF, Horwitz MS: Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice. J Virol 69(12):7674-7681, 1995
25. Autenrieth IB, Beer M, Bohn E, Kaufmann SH, Heesemann J: Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: An essential role for gamma interferon. Infect Immun 62(6): 2590-2599, 1994
26. Barthold SW, Beck DS, Hansen GM, Terwilliger GA, Moody KD: Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 162(1):133-138, 1990
27. Fink MP: Animal models of sepsis. Virulence 5(1):143-153, 2014
28. Angele MK, Schwacha MG, Ayala A, Chaudry IH: Effect of gender and sex hormones on immune responses following shock. Shock 14(2):81-90, 2000
29. Choudhry MA, Schwacha MG, Hubbard WJ, Kerby JD, Rue LW, Bland KI, Chaudry IH: Gender differences in acute response to trauma-hemorrhage. Shock 24(Suppl 1):101-106, 2005
30. Schneider CP, Schwacha MG, Chaudry IH: Influence of gender and age on T-cell responses in a murine model of trauma-hemorrhage: Differences between circulating and tissue-fixed cells. J Appl Physiol (1985) 100(3): 826-833, 2006
31. Marriott I, Huet-Hudson YM: Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res 34(3):177-192, 2006
32. Aoyama M, Kotani J, Usami M: Gender difference in granulocyte dynamics and apoptosis and the role of IL-18 during endotoxin-induced systemic inflammation. Shock 32(4):401-409, 2009
33. Imahara SD, Jelacic S, Junker CE, Okeefe GE: The influence of gender on human innate immunity. Surgery 138(2):275-282, 2005
34. Turnbull IR, Wlzorek JJ, Osborne D, Hotchkiss RS, Coopersmith CM, Buchman TG: Effects of age on mortality and antibiotic efficacy in cecal ligation and puncture. Shock 19(4):310-313, 2003
35. Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, et al.: A genomic storm in critically injured humans. J Exp Med 208(13):2581-2590, 2011
36. Wood JH, Partrick DA, Johnston RB Jr: The inflammatory response to injury in children. Curr Opin Pediatr 22(3):315-320, 2010
37. Calkins CM, Bensard DD, Moore EE, McIntyre RC, Silliman CC, Biffl W, Harken AH, Partrick DA, Offner PJ: The injured child is resistant to multiple organ failure: A different inflammatory response? J Trauma 53(6): 1058-1063, 2002
38. Finnerty CC, Jeschke MG, Herndon DN, Gamelli R, Gibran N, Klein M, Silver G, Arnoldo B, Remick D, Tompkins RG, et al.: Temporal cytokine profiles in severely burned patients: A comparison of adults and children. Mol Med 14(9-10):553-560, 2008
39. George RL, McGwin G Jr, Schwacha MG, Metzger J, Cross JM, Chaudry IH, Rue LW 3rd: The association between sex and mortality among burn patients as modified by age. J Burn Care Rehabil 26(5):416-421, 2005.
40. Krabbe KS, Bruunsgaard H, Hansen CM, Møller K, Fonsmark L, Qvist J, Madsen PL, Kronborg G, Andersen HO, Skinhøj P, et al.: Ageing is associated with a prolonged fever response in human endotoxemia. Clin Diagn Lab Immunol 8(2):333-338, 2001.
41. Raqib R, Qadri F, SarkEr P, Mia SM, Sansonnetti PJ, Albert MJ, Andersson J: Delayed and reduced adaptive humoral immune responses in children with shigellosis compared with in adults. Scand J Immunol 55(4):414-423, 2002
42. Lundgren A, Bhuiyan TR, Novak D, Kaim J, Reske A, Lu YJ, Qadri F, Malley R: Characterization of TH17 responses to Streptococcus pneumoniae in humans: Comparisons between adults and children in a developed and a developing country. Vaccine 30(26):3897-3907, 2012
43. Schneider CP, Schwacha MG, Chaudry IH: Impact of sex and age on bone marrow immune responses in a murine model of trauma-hemorrhage. J Appl Physiol (1985) 102(1):113-121, 2007
44. Kang SC, Matsutani T, Choudhry MA, Schwacha MG, Rue LW, Bland KI, Chaudry IH: Are the immune responses different in middle-aged and young mice following bone fracture, tissue trauma and hemorrhage? Cytokine 26(5):223-230, 2004
45. Brubaker AL, Rendon JL, Ramirez L, Choudhry MA, Kovacs EJ: Reduced neutrophil chemotaxis and infiltration contributes to delayed resolution of cutaneous wound infection with advanced age. J Immunol 190(4): 1746-1757, 2013
46. Chorinchath BB, Kong LY, Mao L, McCallum RE: Age-associated differences in TNF-alpha and nitric oxide production in endotoxic mice. J Immunol 156(4):1525-1530, 1996
47. Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, Kurosawa S, Stepien D, Valentine C, Remick DG: Sepsis: Multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev 93(3):1247-1288, 2013
48. Shay T, Jojic V, Zuk O, Rothamel K, Puyraimond-Zemmour D, Feng T, Wakamatsu E, Benoist C, Koller D, Regev A, et al.: Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc Natl Acad Sci U S A 110(8):2946-2951, 2013
49. Lederer JA, Brownstein BH, Lopez MC, Macmillan S, Delisle AJ, Macconmara MP, Choudhry MA, Xiao W, Lekousi S, Cobb JP, et al.: Comparison of longitudinal leukocyte gene expression after burn injury or traumahemorrhage in mice. Physiol Genomics 32(3):299-310, 2008
50. Brownstein BH, Logvinenko T, Lederer JA, Cobb JP, Hubbard WJ, Chaudry IH, Remick DG, Baker HV, Xiao W, Mannick JA: Commonality and differences in leukocyte gene expression patterns among three models of inflammation and injury. Physiol Genomics 24(3):298-309, 2006
51. Wichmann MW, Zellweger R, DeMaso CM, Ayala A, Williams C, Chaudry IH: Immune function is more compromised after closed bone fracture and hemorrhagic shock than hemorrhage alone. Arch Surg 131(9):995-1000, 1996
52. Wichmann MW, Ayala A, Chaudry IH: Severe depression of host immune functions following closed-bone fracture, soft-tissue trauma, and hemorrhagic shock. Crit Care Med 26(8):1372-1378, 1998
53. Gentile LF, Nacionales DC, Cuenca AG, Armbruster M, Ungaro RF, Abouhamze AS, Lopez C, Baker HV, Moore FA, Ang DN, et al.: Identification and description of a novel murine model for polytrauma and shock. Crit Care Med 41(4):1075-1085, 2013
54. Edgar R, Domrachev M, Lash AE: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30(1):207-210, 2002
55. Leelahavanichkul A, Huang Y, Hu X, Zhou H, Tsuji T, Chen R, Kopp JB, Schnermann J, Yuen PS, Star RA: Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing high mobility group box protein-1. Kidney Int 80(11):1198-1211, 2011
56. Salomao R, Brunialti MK, Rapozo MM, Baggio-Zappia GL, Galanos C, Freudenberg M: Bacterial sensing, cell signaling, and modulation of the immune response during sepsis. Shock 38(3):227-242, 2012
57. Samraj RS, Zingarelli B, Wong HR: Role of biomarkers in sepsis care. Shock 40(5):358-365, 2013
58. Schochl H, Voelckel W, Grassetto A, Schlimp CJ: Practical application of point-of-care coagulation testing to guide treatment decisions in trauma. J Trauma Acute Care Surg 74(6):1587-1598, 2013
59. Murray CK, Hoffmaster RM, Schmit DR, Hospenthal DR, Ward JA, Cancio LC, Wolf SE: Evaluation of white blood cell count, neutrophil percentage, and elevated temperature as predictors of bloodstream infection in burn patients. Arch Surg 142(7):639-642, 2007
60. Fan Y, Yu JL: Umbilical blood biomarkers for predicting early-onset neonatal sepsis. World J Pediatr 8(2):101-108, 2012
61. Lenz A, Franklin GA, Cheadle WG: Systemic inflammation after trauma. Injury 38(12):1336-1345, 2007
62. Wang H, Ma S: The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 26(6):711-715, 2008
63. Cavaillon JM, Annane D: Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 12(3):151-170, 2006
64. Cavaillon JM, Adib-Conquy M, Cloez-Tayarani I, Fitting C: Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: A review. J Endotoxin Res 7(2):85-93, 2001
65. Schwacha MG, Schneider CP, Chaudry IH: Differential expression and tissue compartmentalization of the inflammatory response following thermal injury. Cytokine 17(5):266-274, 2002
66. Cauwels A: Nitric oxide in shock. Kidney Int 72(5):557-565, 2007
67. Juskewitch JE, Knudsen BE, Platt JL, Nath KA, Knutson KL, Brunn GJ, Grande JP: LPS-induced murine systemic inflammation is driven by parenchymal cell activation and exclusively predicted by early MCP-1 plasma levels. Am J Pathol 180(1):32-40, 2012
68. Juskewitch JE, Platt JL, Knudsen BE, Knutson KL, Brunn GJ, Grande JP: Disparate roles of marrow- And parenchymal cellYderived TLR4 signaling in murine LPS-induced systemic inflammation. Sci Rep 2:918, 2012
69. Meisner M, Muller V, Khakpour Z, Toegel E, Redl H: Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model. Shock 19(2):187-190, 2003
70. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF: A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95(1):55-65, 1995
71. Kapetanovic R, Parlato M, Fitting C, Quesniaux V, Cavaillon JM, Adib- Conquy M: Mechanisms of TNF induction by heat-killed Staphylococcus aureus differ upon the origin of mononuclear phagocytes. Am J Physiol Cell Physiol 300(4):C850YC859, 2011
72. Suzuki T, Shimizu T, Yu HP, Hsieh YC, Choudhry MA, Schwacha MG, Chaudry IH: Tissue compartment-specific role of estrogen receptor subtypes in immune cell cytokine production following trauma-hemorrhage. J Appl Physiol (1985) 102(1):163-168, 2007
73. Ayala A, Perrin MM, Wang P, Ertel W, Chaudry IH: Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity. Involvement of cell-associated tumor necrosis factor and reactive nitrogen. J Immunol 147(12):4147-4154, 1991
74. Zhu XL, Zellweger R, Zhu XH, Ayala A, Chaudry IH: Cytokine gene expression in splenic macrophages and Kupffer cells following haemorrhage. Cytokine 7(1):8-14, 1995
75. Wang P, Ba ZF, Morrison MH, Chaudry IH: Differential alterations in cyclic nucleotide levels in Kupffer cells and hepatocytes following traumahemorrhage and resuscitation. Shock 1(6):438-442, 1994
76. Gorgani NN, Ma Y, Clark HF: Gene signatures reflect the marked heterogeneity of tissue-resident macrophages. Immunol Cell Biol 86(3):246-254, 2008
77. Copeland S, Warren HS, Lowry SF, Calvano SE, Remick DG: Inflammation and host response to injury investigators: Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol 12(1):60-67, 2005
78. Namas R, Ghuma A, Hermus L, Zamora R, Okonkwo DO, Billiar TR, Vodovotz Y: The acute inflammatory response in trauma/hemorrhage and traumatic brain injury: Current state and emerging prospects. Libyan J Med 4(3):97-103, 2009
79. Ziebell JM, Morganti-Kossmann MC: Involvement of pro- And antiinflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7(1):22-30, 2010
80. Lichtinghagen R, Musholt PB, Lein M, Romer A, Rudolph B, Kristiansen G, Hauptmann S, Schnorr D, Loening SA, Jung K: Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. Eur Urol 42(4): 398-406, 2002
81. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, et al.: Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1(4):304-313, 2002
82. Orntoft TF, Thykjaer T, Waldman FM, Wolf H, Celis JE: Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas. Mol Cell Proteomics 1(1):37-45, 2002
83. Guo Y, Xiao P, Lei S, Deng F, Xiao GG, Liu Y, Chen X, Li L, Wu S, Chen Y, et al.: How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin (Shanghai) 40(5):426-436, 2008
84. Anderson L, Seilhamer J: A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18(3-4):533-537, 1997
85. Greenbaum D, Colangelo C, Williams K, Gerstein M: Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4(9):117, 2003
86. Stoecklein VM, Osuka A, Lederer JA: Trauma equals dangerVdamage control by the immune system. J Leukoc Biol 92(3):539-551, 2012
87. Smith JW, Gamelli RL, Jones SB, Shankar R: Immunologic responses to critical injury and sepsis. J Intensive Care Med 21(3):160-172, 2006
88. Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D: Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol 12(1):60-67, 2005
89. Rossol M, Heine H, Meusch U, Quandt D, Klein C, Sweet MJ, Hauschildt S: LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol 31(5):379-446, 2011
90. Nagae M, Nishi N, Nakamura-Tsuruta S, Hirabayashi J, Wakatsuki S, Kato R: Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue. J Mol Biol 375(1):119-135, 2008
91. Warren HS, Fitting C, Hoff E, Adib-Conquy M, Beasley-Topliffe L, Tesini B, Liang X, Valentine C, Hellman J, Hayden D, et al.: Resilience to bacterial infection: Difference between species could be due to proteins in serum. J Infect Dis 201(2):223-232, 2010
92. Karp CL: Unstressing intemperate models: How cold stress undermines mouse modeling. J Exp Med 209(6):1069-1074, 2012
93. Chaudry IH: Sepsis: Lessons learned in the last century and future directions. Arch Surg 134(9):922-929, 1999
94. Iskander KN, Craciun FL, Stepien DM, Duffy ER, Kim J, Moitra R, Vaickus LJ, Osuchowski MF, Remick DG: Cecal ligation and punctureYinduced murine sepsis does not cause lung injury. Crit Care Med 41(1):159-170, 2013
95. Hartung T: Look back in angerVwhat clinical studies tell us about preclinical work. ALTEX 30(3):275-291, 2013
96. Bohannon J: Whos afraid of peer review? Science 342(6154):60-65, 2013
97. Warren HS, Tompkins RG, Mindrinos MN, Xiao W, Davis RW: Reply to Cauwels, et al.: Of men, not mice, and inflammation. Proc Natl Acad Sci U S A 110(34):E3151, 2013
98. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/ tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229(4716):869-871, 1985
99. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shockVa review of laboratory models and a proposal. J Surg Res 29(2):189-201, 1980
100. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW 3rd, Bland KI, Chaudry IH: Cecal ligation and puncture. Shock 24(Suppl 1):52-57, 2005
101. Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G: Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 4(2):89-95, 1995
102. Goto M, Zeller WP, Hurley RM, Jong JS, Lee CH: Prophylaxis and treatment of newborn endotoxic shock with anti-lipid. A monoclonal antibodies. Circ Shock 35(1):60-64, 1991
103. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348(6301): 550-552, 1990
104. Krausz MM, Utsunomiya T, Feuerstein G, Wolfe JH, Shepro D, Hechtman HB: Prostacyclin reversal of lethal endotoxemia in dogs. J Clin Invest 67(4):1118-1125, 1981
105. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330(6149):662-664, 1987
106. Qiu P, Cui X, Sun J, Welsch J, Natanson C, Eichacker PQ, Hotchkiss RS, Monneret G, Payen D: Antitumor necrosis factor therapy is associated with improved survival in clinical sepsis trialsVa meta-analysis. Crit Care Med 41(10): 2419-2429, 2013
107. Hotchkiss RS, Monneret G, Payen D: Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy. Nat Rev Immunol 13(12): 862-874, 2013
108. Angus DS: The search for effective therapy for sepsis: Back to the drawing board? JAMA 306(23):2614-2615, 2011
109. Panacek EA, Marshall JC, Albertson TE, Johnson DH, Johnson S, MacArthur RD, Miller M, Barchuk WT, Fischkoff S, Kaul M, et al.: Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab¶)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 32(11):2173-2182, 2004
110. Osuchowski MF, Connett J, Welch K, Granger J, Remick DG: Stratification is the key: Inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med 37(5):1567-1573, 2009
111. Shultz LD, Ishikawa F, Greiner DL: Humanized mice in translational biomedical research. Nat Rev Immunol 7(2):118-130, 2007
112. Usinger J, McDonough JS, Schultz LD, Ferguson TA, Hotchkiss RS: Sepsisinduced human lymphocyte apoptosis and cytokine production in Bhumanized[ mice. J Leukoc Biol 86(2):219-227, 2009
113. Ernst W, Zimara N, Hanses F, Männel DN, Seelbacj-Gobel B, Wege AK: Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis. Infect Immun 81(5):1520-1531, 2013
114. Churchill GA, Airey DC, Allayee H, Angel JM, Attie AD, Beatty J, Beavis WD, Belknap JK, Bennett B, Berrettini W, et al.: The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet 36(11):1133-1137, 2004
115. Threadgill DW, Churchill GA.: Ten years of the Collaborative Cross. Genetics 190(2):291-294, 2012
116. Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG: Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 148(9):2724-2730, 1992
117. Dhainaut JF, Vincent JL, Richard C, Lejeune P, Martin C, Fierobe L, Stephens S, Ney UM, Sopwith M: CDP571, a humanized antibody to human tumor necrosis factor-alpha: Safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group. Crit Care Med 23(9):1461-1469, 1995
118. Reinhart K, Wiegand-Lohnert C, Grimminger F, Kaul M, Withington S, Treacher D, Eckart J, Willatts S, Bouza C, Krausch D, et al.: Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibodyfragment, MAK 195F, in patients with sepsis and septic shock: A multicenter, randomized, placebo-controlled, dose-ranging study. Crit Care Med 24(5): 733-742, 1996
119. Fekade D, Knox K, Hussein K, Melka A, Lalloo DG, Coxon RE, Warrell DA: Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med 335(5):311-315, 1996
120. Van Den Berg JW, Van Der Zee M, de Bruin RW, Van Holten-Neelen C, Bastiaans J, Nagtzaam NM, Ijzermans JN, Benner R, Dik WA: Mild versus strong anti-inflammatory therapy during early sepsis in mice: A matter of life and death. Crit Care Med 39(6):1275-1281, 2011
121. Park HY, Suh GY, Song JU, Yoo H, Jo IJ, Shin TG, Lim SY, Woo S, Jeon K: Early initiation of low-dose corticosteroid therapy in the management of septic shock: A retrospective observational study. Crit Care 16(1):R3, 2012
122. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, Nizet V, Insel PA, Junger WG: ATP release guides neutrophil chemotaxis via P2-2 and A3 receptors. Science 314(5806):1792-1795, 2006
123. Chen Y, Yao Y, Sumi Y, Li A, To UK, Elkhal A, Inoue Y, Woehrle T, Zhang Q, Hauser C, et al.: Purinergic signaling: A fundamental mechanism in neutrophil activation. Sci Signal 3(125):ra45, 2010
124. Haskó G, Linden J, Cronstein B, Pacher P: Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7(9):759-770, 2008
125. Shenkar R, Abraham E: Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: Roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein. J Immunol 163(2):954-962, 1999
126. Abraham E, Arcaroli J, Shenkar R: Activation of extracellular signal-regulated kinases, NF-kappa B, and cyclic adenosine 5¶-monophosphate response element-binding protein in lung neutrophils occurs by differing mechanisms after hemorrhage or endotoxemia. J Immunol 166(1):522-530, 2001
127. Abraham E, Nick JA, Azam T, Kim SH, Mira JP, Svetkauskaite D, He Q, Zamora M, Murphy J, Park JS, et al.: Peripheral blood neutrophil activation patterns are associated with pulmonary inflammatory responses to lipopolysaccharide in humans. J Immunol 176(12):7753-7760, 2006
128. Yang KY, Arcaroli JJ, Abraham E: Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am J Respir Crit Care 167(11):1567-1574, 2003
129. Osuchowski MF, Welch K, Siddiqui J, Remick DG: Circulating cytokine/ inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 177(3):1967-1974, 2006
130. Osuchowski MF, Craciun F, Weixelbaumer KM, Duffy ER, Remick DG: Sepsis chronically in MARS: Systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis. J Immunol 189(9): 4648-4656, 2012
131. Tamayo E, Fernandez A, Almansa R, Carrasco E, Heredia M, Lajo C, Goncalves L, Gómez-Herreras JI, de Lejarazu RO, Bermejo-Martin JF: Proand anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur Cytokine Netw 22(2):82-87, 2011
132. Novotny AR, Reim D, Assfalg V, Altmayr F, Friess HM, Emmanuel K, Holzmann B: Mixed antagonist response and sepsis severity-dependent dysbalance of pro- And anti-inflammatory responses at the onset of postoperative sepsis. Immunobiology 217(6):616-621, 2012
133. Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA: Six at six: Interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 17(6):463-467, 2002
134. Hack CE, de Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood 74(5):1704-1710, 1989
135. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169(1):333-338, 1989
136. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, et al.: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421(6921):384-388, 2002
137. Olofsson PS, Rosas-Ballina M, Levine YA, Tracey KJ: Rethinking inflammation: Neural circuits in the regulation of immunity. Immunol Rev 248(1): 188-204, 2012
138. PoltorakA, He X, Smirnova I, LiuMY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al.: Defective LPS signaling in C3H/HeJ and C57BL/ 10ScCr mice: Mutations in Tlr4 gene. Science 282(5396):2085-2088, 1998
139. Kalis C, Kanzler B, Lembo A, Poltorak A, Galanos C, Freudenberg MA: Tolllike receptor 4 expression levels determine the degree of LPS-susceptibility in mice. Eur J Immunol 33(3):798-805, 2003
140. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, et al.: A network-based analysis of systemic inflammation in humans. Nature 437(7061):1032-1037, 2005
141. Salomao R, Brunialti MK, Gomes NE, Mendes ME, Diaz RS, Komninakis S, Machado FR, Da Silva ID, Rigato O: Toll-like receptor pathway signaling is differently regulated in neutrophils and peripheral mononuclear cells of patients with sepsis, severe sepsis, and septic shock. Crit Care Med 37(1): 132-139, 2009
142. Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, Karl IE: Apoptosis in lymphoid and parenchymal cells during sepsis: Findings in normal and T- And B-cellYdeficient mice. Crit Care Med 25(8):1298-1307, 1997
143. Coopersmith CM, Stromberg PE, Dunne WM, Davis CG, Amiot DM 2nd, Buchman TG, Karl IE, Hotchkiss RS: Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 287(13):1716-1721, 2002
144. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27(7):1230-1251, 1999
145. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr, Hui JJ, Chang KC, Osborne DF, Freeman BD, Cobb JP, Buchman TG, et al.: Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 166(11):6952-6963, 2001
146. Hotchkiss RS, Tinsley KW, Swanson PE, Grayson MH, Osborne DF, Wagner TH, Cobb JP, Coopersmith C, Karl IE: Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 168(5):2493-2500, 2002
147. Albuszies G, Radermacher P, Vogt J, Wachter U, Weber S, Schoaff M, Georgieff M, Barth E: Effect of increased cardiac output on hepatic and intestinal microcirculatory blood flow, oxygenation, and metabolism in hyperdynamic murine septic shock. Crit Care Med 33(10):2332-2338, 2005
148. Dahn MS, Mitchell RA, Lange MP, Smith S, Jacobs LA: Hepatic metabolic response to injury and sepsis. Surgery 117(5):520-530, 1995
149. Wilmore DW, Goodwin CW, Aulick LH, Powanda MC, Mason AD Jr, Pruitt BA Jr: Effect of injury and infection on visceral 1metabolism and circulation. Ann Surg 192(4):491-504, 1980
150. Barth E, Radermacher P, Thiemermann C, Weber S, Georgieff M, Albuszies G: Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock. Crit Care Med 34(2):307-313, 2006
151. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100(4):483-490, 1984
152. Kumar A, Brar R, Wang P, Dee L, Skorupa G, Khadour F, Schulz R, Parrillo
153. Paulus WJ, Vantrimpont PJ, Shah AM: Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89(5):2070, 1994
154. Al-Sadi R, Guo S, Dokladny K, Smith MA, Ye D, Kaza A, Watterson Ma TY: Mechanism of interleukin-1 induced-increase in mouse intestinal permeability in vivo. J Interferon Cytokine Res 32(10):474-484, 2012
155. Al-Sadi R, Guo S, Dokladny K, Alhmound T, Ereifej L, Said HM, Ma TY: Mechanism of interleukin-1 modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation. J Immunol 190(12):6596-6606, 2013
156. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D: Role of interleukin 1 in inflammatory bowel diseaseYenhanced production during active disease. Gut 31(6):686-689, 1990
157. Al-Sadi RM, Ma TY: IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol 178(7):4641-4649, 2007
158. Al-Sadi R, Ye D, Dokladny K, Ma TY: Mechanism of IL-1betaYinduced increase in intestinal epithelial tight junction permeability. J Immunol 180(8): 5653-5661, 2008
159. Clayburgh DR, Musch MW, Leitges M, Fu YX, Turner JR: Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNFmediated diarrhea in vivo. J Clin Invest 116(10):2682-2694, 2006
160. Clayburgh DR, Barrett TA, Tang Y, Meddings JB, Van Eldik LJ, Watterson DM, Clarke LL, Mrsny RJ, Turner JR: Epithelial myosin light chain kinaseYdependent barrier dysfunction mediates T cell activationYinduced diarrhea in vivo. J Clin Invest 115(10):2702-2715, 2005
161. Barreau F, Meinzer U, Chareyre F, Berrebi D, Niwa-Kawakita M, Dussaillant M, Foligne B, Ollendorff V, Heyman M, Bonacorsi S, et al.: CARD15/NOD2 is required for Peyers patches homeostasis in mice. PLoS One 2(6):e523, 2007
162. Barreau F, Madre C, Meinzer U, Berrebi D, Dussaillant M, Merlin F, Eckmann L, Karin M, Sterkers G, Bonacorsi S: Nod2 regulates the host response towards microflora by modulating T cell function and epithelial permeability in mouse Peyers patches. Gut 59(2):207-217, 2010
163. Schmitz H, Fromm M, Bentzel CJ, Scholz P, Detjen K, Mankertz J, Bode H, Epple HJ, Riecken EO, Schulzke JD: Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 112 (1):137-146, 1999
164. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, Said HM: TNF-alphaYinduced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 286(3):G367YG376, 2004
165. Ma TY, Boivin MA, Ye D, Pedram A, Said HM: Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: Role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol 288(3):G422YG430, 2005
166. Mason KL, Rogers LM, Soares EM, Bani-Hashemi T, Erb Downward J, Agnew D, Peters-Golden M, Weinberg JB, Crofford LJ, Aronoff DM: Intrauterine group A streptococcal infections are exacerbated by prostaglandin E2. J Immunol 191(5):2457-2465, 2013
167. Foster SL, Hargreaves DC, Medzhitov R: Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447(7147): 972-978, 2007
168. Del Fresno C, García-Rio F, Gómez-Piña V, Soares-Schanoski A, Fernández- Ruíz I, Jurado T, Kajiji T, Shu C, Marín E, Gutierrez Del Arroyo A, et al.: Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: Demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 182(10):6494-6507, 2009
169. MendesME, Baggio-Zappia GL, Brunialti MK, Fernandes Mda L, RapozoMM, Salomao R: Differential expression of Toll-like receptor signaling cascades in LPS-tolerant human peripheral blood mononuclear cells. Immunobiology 216(3):285-295, 2011
170. Williams A, Wang JJ, Wang L, Sun X, Fischer JE, Hasselgren PO: Sepsis in mice stimulates muscle proteolysis in the absence of IL-6. Am J Physiol 275(6 Pt 2):R1983YR1991, 1998
171. Klaude M, Mori M, Tjäder I, Gustafsson T, Wernerman J, Rooyackers O: Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. Clin Sci (Lond) 122(3):133-142, 2012
172. Lang CH, Lynch CJ, Vary TC: BCATm deficiency ameliorates endotoxininduced decrease in muscle protein synthesis and improves survival in septic mice. Am J Physiol Regul Integr Comp Physiol 299(3):R935YR944, 2010
173. Plank LD, Connolly AB, Hill GL: Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis. Ann Surg 228(2):146-158, 1998
174. Weijer S, Schoenmakers SH, Florquin S, Levi M, Vlasuk GP, Rote WE, Reitsma PH, Spek CA, Van Der Poll T: Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice. J Infect Dis 189(12): 2308-2317, 2004
175. Aasen AO, Smith-Erichsen N, Amundsen E: Studies on pathological plasma proteolysis in patients with septicemia. Scand J Clin Lab Invest Suppl 178: 37-45, 1985
176. Franco RF, de Jonge E, Dekkers PE, Timmerman JJ, Spek CA, Van Deventer SJ, Van Deursen P, Van Kerkhoff L, Van Gemen B, ten Cate H, et al.: The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: Relationship with activation of coagulation. Blood 96(2):554-559, 2000
177. Solan PD, Dunsmore KE, Denenberg AG, Odoms K, Zingarelli B, Wong HR: A novel role for matrix metalloproteinase-8 in sepsis. Crit Care Med 40(2): 379-387, 2012
178. Crouser ED, Julian MW, Huff JE, Struck J, Cook CH: Carbamoyl phosphate synthase-1: A marker of mitochondrial damage and depletion in the liver during sepsis. Crit Care Med 34(9):2439-2446, 2006
179. Haden DW, Suliman HB, Carraway MS, Welty-Wolf KE, Ali AS, Shitara H, Yonekawa H, Piantadosi CA: Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis. Am J Respir Crit Care Med 176(8):768-777, 2007
180. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, Singer M: Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360(9328):219-223, 2002
181. Carré JE, Orban JC, Re L, Felsmann K, Iffert W, Bauer M, Suliman HB, Piantadosi CA, Mayhew TM, Breen P: Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med 182(6):745-751, 2010
182. Watanabe E, Muenzer JT, Hawkins WG, Davis CG, Dixon DJ, McDunn JE, Brackett DJ, Lerner MR, Swanson PE, Hotchkiss RS: Sepsis induces extensive autophagic vacuolization in hepatocytes: A clinical and laboratory-based study. Lab Invest 89(5):549-561, 2009
183. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, Kishi C, Kc W, Carrero JA, Hunt S, et al.: A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456(7219): 259-263, 2008
184. Conway KL, Kuballa P, Song JH, Patel KK, Castoreno AB, Yilmaz OH, Jijon HB, Zhang M, Aldrich LN, Villablanca EJ, et al.: Atg16l1 is required for autophagy in intestinal epithelial cells and protection of mice from Salmonella infection. Gastroenterology 145(6):1347-1357, 2013
185. Raeven P, Feichtinger GA, Weixelbaumer KM, Atzenhofer S, Redl H, Van Griensven M, Bahrami S, Osuchowski MF: Compartment-specific expression of plasminogen activator inhibitor-1 correlates with severity/outcome of murine polymicrobial sepsis. Thromb Res 129(5):e238Ye245, 2012
186. Raeven P, Feichtinger GA, Weixelbaumer KM, Atzenhofer S, Redl H, Van Griensven M, Bahrami S, Osuchowski MF: A non-lethal traumatichemorrhagic insult strongly modulates the compartment-specific PAI-1 response in the subsequent polymicrobial sepsis. PLoS One 8(2):e55467, 2013
187. Shapiro NI, Schuetz P, Yano K, Sorasaki M, Parikh SM, Jones AE, Trzeciak S, Ngo L, Aird WC: The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit Care 14(5):R182, 2010
188. Genovese T, Mazzon E, Esposito E, Di Paola R, Murthy K, Neville L, Bramanti P, Cuzzocrea S: Effects of a metalloporphyrinic peroxynitrite decomposition catalyst, ww-85, in a mouse model of spinal cord injury. Free Radic Res 43(7):631-645, 2009
189. Genovese T, Mazzon E, Esposito E, Muià C, Di Paola R, Di Bella P, Bramanti P, Cuzzocrea S: Role of endogenous glutathione in the secondary damage in experimental spinal cord injury in mice. Neurosci Lett 423(1):41-46, 2007
190. Bastani NE, Kostovski E, Sakhi AK, Karlsen A, Carlsen MH, Hjeltnes N, Blomhoff R, Iversen PO: Reduced antioxidant defense and increased oxidative stress in spinal cord injured patients. Arch Phys Med Rehabil 93(12): 2223-2228.e2, 2012
191. Ling H, Edelstein C, Gengaro P, Meng X, Lucia S, Knotek M, Wangsiripaisan A, Shi Y, Schrier R: Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice. Am J Physiol 277(3 Pt 2): F383YF390, 1999
192. Barrera-Chimal J, Pérez-Villalva R, Cortés-González C, Ojeda-Cervantes M, Gamba G, Morales-Buenrostro LE, Bobadilla NA: HSP72 is an early and sensitive biomarker to detect acute kidney injury. EMBO Mol Med 3(1): 5-20, 2011
193. Zhang QH, Chen Q, Kang JR, Liu C, Dong N, Zhu XM, Sheng ZY, Yao YM: Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury. J Neuroinflammation 8:118, 2011
194. Rothenbach PA, Dahl B, Schwartz JJ, Okeefe GE, Yamamoto M, Lee WM, Horton JW, Yin HL, Turnage RH: Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol (1985) 96(1):25-31, 2003
195. Lee PS, Drager LR, Stossel TP, Moore FD, Rogers SO: Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients. Ann Surg 243(3):399-403, 2006
196. Huang LF, Yao YM, Li JF, Dong N, Liu C, Yu Y, He LX, Sheng ZY: Reduction of plasma gelsolin levels correlates with development of multiple organ dysfunction syndrome and fatal outcome in burn patients. PLoS One 6(11):e25748, 2011